Vedolizumab Treatment for Ulcerative Colitis in an Elderly Multimorbid Patient with Hemophilia A
The treatment of inflammatory bowel diseases (IBD) can be challenging, especially in elderly multimorbid patients. Since incidence and prevalence rates of IBD are rising steadily, treatment of older patients with relevant and also rare comorbidities will be of increasing relevancy for caregivers. He...
Main Authors: | Holger Schäffler, Astrid Huth, Georg Lamprecht, Olaf Anders |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2017-12-01
|
Series: | Case Reports in Gastroenterology |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/485372 |
Similar Items
-
Primary sclerosing cholangitis associated with severe ulcerative colitis in a young man
by: José Cândido Caldeira Xavier Júnior, et al.
Published: (2013-12-01) -
Risk of postoperative complications among ulcerative colitis patients treated preoperatively with vedolizumab: a matched case-control study
by: Jeong Yeon Kim, et al.
Published: (2020-03-01) -
Early Clinical Remission Is a Predictor of Long-Term Remission with the Use of Vedolizumab for Ulcerative Colitis
by: Keiichi Haga, et al.
Published: (2022-10-01) -
Primary Sclerosing Cholangitis Associated with Severe Ulcerative Colitis in a Young Woman: Case Report
by: Somaieh Matin, et al.
Published: (2019-10-01) -
Hypereosinophilic Syndrome Secondary to Ulcerative Colitis and Primary Sclerosing Cholangitis
by: Davi Viana Ramos, et al.
Published: (2023-01-01)